Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.
about
MDMA for the treatment of mood disorder: all talk no substance?3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress DisorderPharmacological enhancement of exposure-based treatment in PTSD: a qualitative review3,4-methylenedioxymethamphetamine (MDMA): current perspectivesThe safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyDurability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in othersFrom Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric DisordersLegal highs: staying on top of the flood of novel psychoactive substancesEmpathic accuracy and oxytocin after tryptophan depletion in adults at risk for depression.Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis)No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activationHow MDMA's pharmacology and pharmacokinetics drive desired effects and harms.A window into the intoxicated mind? Speech as an index of psychoactive drug effectsAcute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptorMDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study.The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.Effects of MDMA and Intranasal oxytocin on social and emotional processing.Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studiesPlasma oxytocin concentrations following MDMA or intranasal oxytocin in humans'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content.MDMA effects consistent across laboratories.A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).MDMA enhances emotional empathy and prosocial behaviorHistory and future of the Multidisciplinary Association for Psychedelic Studies (MAPS).The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder.Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy.Clinical applications of hallucinogens: A review.Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol).Next-generation treatments for mental disorders.Acute Effects of the Novel Psychoactive Drug 2C-B on EmotionsEffects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels.The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.Editorial: Oxytocin's routes in social behavior: into the 21st centuryAcute effects of MDMA on autonomic cardiac activity and their relation to subjective prosocial and stimulant effects.Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders.Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to DateOxytocin decreases cocaine taking, cocaine seeking, and locomotor activity in female rats.Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.
P2860
Q21558551-2655E362-DED1-4BCC-9B38-257626424C9AQ22299243-37E4DE0B-231F-42F7-8C38-CDD3E76B27CCQ22305514-355AE457-69AB-4132-98AC-BFADD6BFA699Q24602762-501CE136-F5A4-405B-830F-174453F198A6Q24606265-96E6D12F-7D20-46AB-B8B7-45BA718ABFADQ24620135-D569A362-A345-4947-A34A-6940955F7F8FQ24630561-0FF2113C-32FA-45C0-A948-D5CCFD4340B9Q26770469-3FB1ABAC-5508-485F-91C4-A5BD8FF12AA3Q26799231-6183199D-7AF8-47F8-AE61-6E825F32B877Q27324786-E1B661F9-E6AD-4CFA-A24F-6BF4FCEAAAB4Q27329826-4928B014-4260-4D8A-AB61-5FFD37AD6100Q28540131-FBFD1572-1F8E-41FD-AEB1-405425CA7958Q30357945-19ED953B-ABAD-45D8-8EE9-E70605434860Q30404060-9BC8345F-7A66-47A2-9F7B-640331FF8F10Q30544870-19FA25C6-B8A1-418C-A25A-6D29CFFF3BDFQ33390410-2D6304D0-4CC6-4B8F-ACC3-9B39AD3D3834Q33455500-D7E5640D-B75E-41A5-A748-54BC6905A6D7Q33620569-8293C614-76B8-414B-A916-C52D1145072FQ33641345-0DCB930B-0C8C-4307-904F-70C5DA4329B9Q33870495-08345713-50E4-489E-A118-764794656804Q34021568-0E39CB0F-DD17-494E-BB20-6A3574B2A652Q34167689-F2B85F3A-CEE4-4573-9A4C-BC5D436BC5EDQ34309474-0D272EF7-E886-49BB-93E9-6754BB15595AQ34375625-93E2571B-7347-4694-A893-8E3D3E2183C7Q34420092-E409A4C0-630E-4679-8EFD-1C230886898CQ34495787-D8C3CA14-0F3A-4243-B929-E195FBDA731EQ34502080-6F81344E-7C64-4B1C-8B81-A0018EE1C865Q34523797-BDCF9683-26A9-4B7A-8184-612A9BF88468Q34535259-FA0116C5-A5FA-4AC7-A2B8-BF87345736BAQ34551204-474610B5-EADC-4CB5-A3CE-1A85783A8DDAQ34643734-D55938A8-5A69-4C73-98FE-43702E327421Q34674320-8EE23E41-FA2E-4567-AB8D-354B1BB2B3B7Q35554326-E8448978-7D11-4B28-89B5-A3C009D67F4FQ35754068-C2BBBF13-E70B-4A29-9E46-678AF16E9EE3Q35992610-5D6F92DB-0346-48F8-B24B-DC54B76C43E0Q36253278-F5083A29-3CAE-4898-8662-0338EE52F489Q36685572-8994495E-3674-4979-A129-F8B7A1CAD9FCQ36749707-3474E24E-C5FD-4271-BD9E-ADBF6B196BCCQ36768091-20A8CCFE-44B6-4C45-9E90-10AB6BEEAFBDQ37113859-55A14480-F5E0-4829-BBAA-2D16968CB19E
P2860
Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Increased oxytocin concentrati ...... thamphetamine) administration.
@ast
Increased oxytocin concentrati ...... thamphetamine) administration.
@en
Increased oxytocin concentrati ...... thamphetamine) administration.
@nl
type
label
Increased oxytocin concentrati ...... thamphetamine) administration.
@ast
Increased oxytocin concentrati ...... thamphetamine) administration.
@en
Increased oxytocin concentrati ...... thamphetamine) administration.
@nl
prefLabel
Increased oxytocin concentrati ...... thamphetamine) administration.
@ast
Increased oxytocin concentrati ...... thamphetamine) administration.
@en
Increased oxytocin concentrati ...... thamphetamine) administration.
@nl
P2093
P1433
P1476
Increased oxytocin concentrati ...... ethamphetamine) administration
@en
P2093
A R T Donders
G J H Dumont
J K Buitelaar
J M A van Gerven
R J Verkes
R van der Steen
P304
P356
10.1080/17470910802649470
P50
P577
2009-01-01T00:00:00Z